Clinical trial
Treatment of Paroxysmal Atrial Fibrillation With the Sphere-9™ Catheter and Affera™ Integrated Mapping and Ablation System in China
NCT07789925 is registered in ClinicalTrials.gov with Medtronic Cardiac Ablation Solutions as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Paroxysmal Atrial Fibrillation With the Sphere-9™ Catheter and Affera™ Integrated Mapping and Ablation System in China
- Lead sponsor
- Medtronic Cardiac Ablation Solutions
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 2, 2026
- Completion date
- April 30, 2028
- Enrollment
- 180 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
paroxysmal atrial fibrillation (paf)